Eli Lilly Cash on Hand 2010-2024 | LLY

Eli Lilly cash on hand for the quarter ending December 31, 2024 was $3.423B, a 16.92% increase year-over-year.

  • Eli Lilly cash on hand for 2024 was $3.423B, a 16.92% increase from 2023.
  • Eli Lilly cash on hand for 2023 was $2.928B, a 32.37% increase from 2022.
  • Eli Lilly cash on hand for 2022 was $2.212B, a 43.41% decline from 2021.

Eli Lilly Cash on Hand 2010-2024 | LLY

  • Eli Lilly cash on hand for 2024 was $3.423B, a 16.92% increase from 2023.
  • Eli Lilly cash on hand for 2023 was $2.928B, a 32.37% increase from 2022.
  • Eli Lilly cash on hand for 2022 was $2.212B, a 43.41% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B